[144] Doximity, Inc. SEC Filing

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) Form 144 notifies the market that a person plans to sell 20,000 shares of Common stock through Morgan Stanley Smith Barney LLC on 08/15/2025. The filing lists an aggregate market value of $1,275,566.00 and reports 187,299,459 shares outstanding. The shares to be sold were acquired the same day, 08/15/2025, by stock option exercise from the issuer and paid for in cash. The filer also reported two recent sales in the past three months: 10,000 shares sold on 06/25/2025 for $600,000.00 and 10,000 shares sold on 05/23/2025 for $505,796.00. The signer certifies no undisclosed material adverse information.

Positive

• Transparent disclosure of planned sale, acquisition method, broker, and dollar amounts consistent with Rule 144 requirements
• Recent sales fully reported, showing prior transactions and gross proceeds for market clarity

Negative

• Insider liquidity events (option exercise and planned sale) indicate shares were sold by an insider in the past three months
• No trading plan date is provided on the form to indicate whether sales are pursuant to a Rule 10b5-1 plan

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure showing option exercise and planned sale of 20,000 shares; materiality appears limited.

The Form 144 documents a planned sale executed through a broker with clear acquisition details: the shares were acquired via stock option exercise from the issuer on the same date as the planned sale and paid in cash. Two prior sales by the same person in the past three months are recorded, totaling 20,000 shares and gross proceeds of $1,105,796.00. As a compliance filing, it provides transparent information for market participants but does not include operational or financial performance details.

Corporate Governance Expert

TL;DR: Proper Rule 144 disclosure completed; shows insider liquidity events but no governance or control changes disclosed.

The notice complies with Rule 144 format by identifying the broker, share class, acquisition method, and recent sales. The acquisition method (stock option exercise from the issuer) and immediate planned sale are explicitly stated, and the signer affirms absence of undisclosed material adverse information. There is no indication of a change in control, related-party transaction beyond ordinary option exercise, or a trading plan date provided on this form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	1275566.00	187299459	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Stock Option Exercise	ISSUER			20000	08/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	06/25/2025	10000	600000.00
TIMOTHY CABRAL 500 3rd Street Ste 510 San Francisco CA 94107	Common	05/23/2025	10000	505796.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What quantity of DOCS shares is the filer proposing to sell on 08/15/2025?

The filer proposes to sell 20,000 shares of Common stock on 08/15/2025 through Morgan Stanley Smith Barney LLC.

How were the 20,000 DOCS shares acquired?

The 20,000 shares were acquired on 08/15/2025 by stock option exercise from the issuer and paid for in cash.

What are the recent insider sales reported in the past three months for DOCS?

Two sales are reported: 10,000 shares sold on 06/25/2025 for $600,000.00 and 10,000 shares sold on 05/23/2025 for $505,796.00.

What is the aggregate market value and shares outstanding noted in the filing?

The filing lists an aggregate market value of $1,275,566.00 for the shares to be sold and 187,299,459 shares outstanding.

Does the Form 144 state whether the filer knows of any undisclosed material adverse information?

Yes. The person signing the notice represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.